BIOMAT Database Logo BIOMAT Database Logo

Novel cyclic compounds as potent phosphodiesterase 4 inhibitors. 1998

W He, and F C Huang, and B Hanney, and J Souness, and B Miller, and G Liang, and J Mason, and S Djuric
Department of Medicinal Chemistry, SW 8 Rhône-Poulenc Rorer Central Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, USA.

The synthesis and biological activity of a novel series of 2, 2-disubstituted indan-1,3-dione-based PDE4 inhibitors are described. This structurally unique class of PDE4 inhibitors is markedly different from the known PDE4 inhibitors such as RP 73401 (2) and CDP 840 (3). Structure-activity relationship (SAR) studies led to the identification of inhibitors with nanomolar potency and oral activity in a murine endotoxemia model for TNF-alpha inhibition. Unlike other classical PDE4 inhibitors, several analogues were found to be nonemetic in a canine emesis model at intravenous doses of up to 3 mg/kg.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010726 Phosphodiesterase Inhibitors Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterase Antagonists,Phosphodiesterase Inhibitor,Phosphoric Diester Hydrolase Inhibitors,Antiphosphodiesterases,Inhibitor, Phosphodiesterase
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea

Related Publications

W He, and F C Huang, and B Hanney, and J Souness, and B Miller, and G Liang, and J Mason, and S Djuric
Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase.
August 1978, Experientia,
W He, and F C Huang, and B Hanney, and J Souness, and B Miller, and G Liang, and J Mason, and S Djuric
Substituted aminopyridines as potent and selective phosphodiesterase-4 inhibitors.
February 2003, Bioorganic & medicinal chemistry letters,
W He, and F C Huang, and B Hanney, and J Souness, and B Miller, and G Liang, and J Mason, and S Djuric
Novel triazines as potent and selective phosphodiesterase 10A inhibitors.
September 2012, Bioorganic & medicinal chemistry letters,
W He, and F C Huang, and B Hanney, and J Souness, and B Miller, and G Liang, and J Mason, and S Djuric
Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents.
August 1999, Current opinion in chemical biology,
W He, and F C Huang, and B Hanney, and J Souness, and B Miller, and G Liang, and J Mason, and S Djuric
Substituted 2-pyridinemethanol derivatives as potent and selective phosphodiesterase-4 inhibitors.
June 2003, Bioorganic & medicinal chemistry letters,
W He, and F C Huang, and B Hanney, and J Souness, and B Miller, and G Liang, and J Mason, and S Djuric
Cyclic GMP phosphodiesterase inhibitors. 1. The discovery of a novel potent inhibitor, 4-((3,4-(methylenedioxy)benzyl)amino)-6,7,8-trimethoxyquinazoline.
November 1993, Journal of medicinal chemistry,
W He, and F C Huang, and B Hanney, and J Souness, and B Miller, and G Liang, and J Mason, and S Djuric
Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors.
September 2012, Journal of medicinal chemistry,
W He, and F C Huang, and B Hanney, and J Souness, and B Miller, and G Liang, and J Mason, and S Djuric
Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal Compounds.
April 2020, Journal of medicinal chemistry,
W He, and F C Huang, and B Hanney, and J Souness, and B Miller, and G Liang, and J Mason, and S Djuric
Novel heterocyclic-fused pyridazinones as potent and selective phosphodiesterase IV inhibitors.
May 1997, Journal of medicinal chemistry,
W He, and F C Huang, and B Hanney, and J Souness, and B Miller, and G Liang, and J Mason, and S Djuric
Analogues of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 3',5'-phosphate phosphodiesterase.
January 1971, Molecular pharmacology,
Copied contents to your clipboard!